PL3337812T3 - Sposób zmniejszenia zawartości białek komórki gospodarza w chromatografii powinowactwa - Google Patents
Sposób zmniejszenia zawartości białek komórki gospodarza w chromatografii powinowactwaInfo
- Publication number
- PL3337812T3 PL3337812T3 PL16757608T PL16757608T PL3337812T3 PL 3337812 T3 PL3337812 T3 PL 3337812T3 PL 16757608 T PL16757608 T PL 16757608T PL 16757608 T PL16757608 T PL 16757608T PL 3337812 T3 PL3337812 T3 PL 3337812T3
- Authority
- PL
- Poland
- Prior art keywords
- reduction
- host cell
- affinity chromatography
- cell proteins
- proteins
- Prior art date
Links
- 238000001042 affinity chromatography Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
- C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562208523P | 2015-08-21 | 2015-08-21 | |
| PCT/EP2016/069604 WO2017032686A1 (en) | 2015-08-21 | 2016-08-18 | Method for the reduction of host cell proteins in affinity chromatography |
| EP16757608.1A EP3337812B1 (en) | 2015-08-21 | 2016-08-18 | Method for the reduction of host cell proteins in affinity chromatography |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3337812T3 true PL3337812T3 (pl) | 2021-10-11 |
Family
ID=56802471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16757608T PL3337812T3 (pl) | 2015-08-21 | 2016-08-18 | Sposób zmniejszenia zawartości białek komórki gospodarza w chromatografii powinowactwa |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20180186832A1 (pl) |
| EP (1) | EP3337812B1 (pl) |
| JP (4) | JP6968055B2 (pl) |
| KR (2) | KR102691585B1 (pl) |
| CN (2) | CN116063375A (pl) |
| AU (1) | AU2016312909B2 (pl) |
| CA (1) | CA2992420A1 (pl) |
| ES (1) | ES2877532T3 (pl) |
| HR (1) | HRP20211026T1 (pl) |
| IL (1) | IL257146B2 (pl) |
| MX (1) | MX388197B (pl) |
| PL (1) | PL3337812T3 (pl) |
| SI (1) | SI3337812T1 (pl) |
| WO (1) | WO2017032686A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE059173T2 (hu) | 2014-09-10 | 2022-10-28 | Procter & Gamble | Nemszõtt kelme |
| PL3337812T3 (pl) * | 2015-08-21 | 2021-10-11 | F. Hoffmann-La Roche Ag | Sposób zmniejszenia zawartości białek komórki gospodarza w chromatografii powinowactwa |
| WO2017032611A1 (en) | 2015-08-21 | 2017-03-02 | F. Hoffmann-La Roche Ag | Method for the reduction of host cell proteins in affinity chromatography |
| EP3788150A4 (en) * | 2018-05-04 | 2022-01-26 | Sigma-Aldrich Co. LLC | PRODUCTION OF RECOMBINANT PROTEINS WITH REDUCED LEVELS OF HOST CELL PROTEINS |
| US20220267369A1 (en) * | 2018-07-25 | 2022-08-25 | Merck Sharp & Dohme Corp. | Methods of separating host cell lipases from a production protein in chromatographic processes |
| CA3127174A1 (en) * | 2019-01-23 | 2020-07-30 | Daiichi Sankyo Company, Limited | Methods for purifying antibodies comprising of a process by using activated carbon materials |
| BR112022005410A2 (pt) * | 2019-09-23 | 2022-06-21 | Merck Sharp & Dohme | Métodos e composições compreendendo um anticorpo monoclonal anti-ctla4 com proteínas de célula hospedeira reduzidas e estabilidade de polissorbato 80 aumentada |
| WO2023284073A1 (zh) * | 2021-07-13 | 2023-01-19 | 江苏荃信生物医药股份有限公司 | 降低单克隆抗体生产中宿主细胞蛋白含量的亲和纯化方法、抗人ifnar1单克隆抗体浓缩溶液的制备方法以及液体制剂 |
| WO2023137143A1 (en) * | 2022-01-14 | 2023-07-20 | Shattuck Labs, Inc. | Methods of contaminant removal from protein isolates |
| WO2024178239A1 (en) * | 2023-02-22 | 2024-08-29 | Shattuck Labs, Inc. | Engineered cell lines and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101119448B1 (ko) | 2002-09-11 | 2012-03-15 | 추가이 세이야쿠 가부시키가이샤 | 단백질 정제 방법 |
| TW200902555A (en) | 2005-01-03 | 2009-01-16 | Hoffmann La Roche | Antibodies against IL-13 receptor alpha 1 and uses thereof |
| EP2377886A1 (en) * | 2005-12-12 | 2011-10-19 | F. Hoffmann-La Roche AG | Antibody glycosylation in the variable region |
| WO2007109163A2 (en) | 2006-03-16 | 2007-09-27 | Amgen Inc | Wash buffer and method of using |
| WO2011038894A1 (en) | 2009-10-01 | 2011-04-07 | F. Hoffmann-La Roche Ag | Protein a chromatography |
| ES2982297T3 (es) | 2009-12-18 | 2024-10-15 | Novartis Ag | Método de cromatografía de afinidad |
| US20130096284A1 (en) * | 2010-06-21 | 2013-04-18 | Kyowa Hakko Kirin Co., Ltd. | Method for purifying protein using amino acid |
| ES2869396T3 (es) | 2013-05-15 | 2021-10-25 | Medimmune Ltd | Purificación de polipéptidos producidos de manera recombinante |
| TWI596107B (zh) * | 2013-06-25 | 2017-08-21 | 卡地拉保健有限公司 | 單株抗體之新穎純化方法 |
| US10144774B2 (en) * | 2013-07-01 | 2018-12-04 | Csl Behring Ag | Method for purifying IgG |
| MX2016001601A (es) * | 2013-08-19 | 2016-05-02 | Hoffmann La Roche | Separacion de anticuerpos biespecificos y subproductos de produccion de anticuerpos biespecificos utilizando cromatografia de hidroxiapatita. |
| KR102571391B1 (ko) * | 2013-09-13 | 2023-08-29 | 제넨테크, 인크. | 정제된 재조합 폴리펩티드를 포함하는 방법 및 조성물 |
| CN103497248B (zh) * | 2013-09-22 | 2016-08-10 | 中国抗体制药有限公司 | 一种从细胞培养上清中分离纯化抗体的方法 |
| PL3337812T3 (pl) | 2015-08-21 | 2021-10-11 | F. Hoffmann-La Roche Ag | Sposób zmniejszenia zawartości białek komórki gospodarza w chromatografii powinowactwa |
| WO2017032611A1 (en) | 2015-08-21 | 2017-03-02 | F. Hoffmann-La Roche Ag | Method for the reduction of host cell proteins in affinity chromatography |
-
2016
- 2016-08-18 PL PL16757608T patent/PL3337812T3/pl unknown
- 2016-08-18 EP EP16757608.1A patent/EP3337812B1/en active Active
- 2016-08-18 KR KR1020187004868A patent/KR102691585B1/ko active Active
- 2016-08-18 SI SI201631245T patent/SI3337812T1/sl unknown
- 2016-08-18 HR HRP20211026TT patent/HRP20211026T1/hr unknown
- 2016-08-18 WO PCT/EP2016/069604 patent/WO2017032686A1/en not_active Ceased
- 2016-08-18 CN CN202211094785.4A patent/CN116063375A/zh active Pending
- 2016-08-18 KR KR1020247025729A patent/KR20240121902A/ko active Pending
- 2016-08-18 MX MX2018001536A patent/MX388197B/es unknown
- 2016-08-18 CN CN201680042079.1A patent/CN107849087B/zh active Active
- 2016-08-18 AU AU2016312909A patent/AU2016312909B2/en active Active
- 2016-08-18 IL IL257146A patent/IL257146B2/en unknown
- 2016-08-18 ES ES16757608T patent/ES2877532T3/es active Active
- 2016-08-18 JP JP2018509846A patent/JP6968055B2/ja active Active
- 2016-08-18 CA CA2992420A patent/CA2992420A1/en active Pending
-
2018
- 2018-02-20 US US15/900,461 patent/US20180186832A1/en not_active Abandoned
-
2021
- 2021-07-30 JP JP2021124951A patent/JP7258964B2/ja active Active
-
2023
- 2023-04-05 JP JP2023061111A patent/JP7610638B2/ja active Active
-
2024
- 2024-12-20 JP JP2024224620A patent/JP2025031829A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7610638B2 (ja) | 2025-01-08 |
| JP2018531895A (ja) | 2018-11-01 |
| JP2025031829A (ja) | 2025-03-07 |
| HK1251584A1 (zh) | 2019-02-01 |
| JP2021176900A (ja) | 2021-11-11 |
| ES2877532T3 (es) | 2021-11-17 |
| KR20240121902A (ko) | 2024-08-09 |
| IL257146B2 (en) | 2025-01-01 |
| US20180186832A1 (en) | 2018-07-05 |
| EP3337812A1 (en) | 2018-06-27 |
| KR20180034500A (ko) | 2018-04-04 |
| IL257146A (en) | 2018-03-29 |
| US20220169675A1 (en) | 2022-06-02 |
| JP7258964B2 (ja) | 2023-04-17 |
| IL257146B1 (en) | 2024-09-01 |
| KR102691585B1 (ko) | 2024-08-05 |
| JP2023076617A (ja) | 2023-06-01 |
| CN107849087A (zh) | 2018-03-27 |
| CN107849087B (zh) | 2022-09-06 |
| HRP20211026T1 (hr) | 2021-10-01 |
| MX2018001536A (es) | 2018-04-24 |
| AU2016312909B2 (en) | 2022-12-08 |
| CA2992420A1 (en) | 2017-03-02 |
| AU2016312909A1 (en) | 2018-02-22 |
| CN116063375A (zh) | 2023-05-05 |
| BR112018001511A2 (pt) | 2018-09-18 |
| SI3337812T1 (sl) | 2021-08-31 |
| WO2017032686A1 (en) | 2017-03-02 |
| EP3337812B1 (en) | 2021-04-28 |
| MX388197B (es) | 2025-03-19 |
| JP6968055B2 (ja) | 2021-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL257146A (en) | A method for reducing host cell proteins in affinity chromatography | |
| IL254965A0 (en) | fusion proteins | |
| EP3140763A4 (en) | Binding affinity prediction system and method | |
| IL290358A (en) | Preparations and methods for detecting host cell proteins | |
| ZA201705712B (en) | Host cell protein modification | |
| EP3010527A4 (en) | Method for assessing protein identity and stability | |
| HUP1500363A2 (en) | Method for increasing the galactose content of recombinant proteins | |
| EP3297661A4 (en) | Method of improving characteristics of proteins | |
| IL250165A0 (en) | Cation exchange chromatographic support and method for using it | |
| IL257170B (en) | Stable proteins and methods for their design | |
| SG11201701965VA (en) | Soluble intein fusion proteins and methods for purifying biomolecules | |
| EP3312278A4 (en) | Protein expression method | |
| EP3265470A4 (en) | Electrophoresis and electroblotting systems and methods | |
| EP3260862A4 (en) | Method for suppressing protein adsorption | |
| IL259181A (en) | Opposite ph-salt gradients for improved protein separations | |
| IL259180A (en) | Improved protein separation in ion exchange chromatography | |
| GB201503218D0 (en) | Particles comprising fusion proteins | |
| EP3299450A4 (en) | Induced syncytiotrophoblast and preparation method for progenitor cell thereof | |
| EP3182997A4 (en) | Affinity proteins and uses thereof | |
| GB201506117D0 (en) | Method for chromatography | |
| PL3337817T3 (pl) | Sposób zmniejszania zawartości białek komórek gospodarza w chromatografii powinowactwa | |
| GB201506113D0 (en) | Method for chromatography | |
| SG10202010606YA (en) | Method for reducing the trisulfide level in proteins | |
| EP3188826A4 (en) | Systems and methods for assessing therapeutic proteins | |
| GB201502590D0 (en) | Method and apparatus for designing proteins |